Tegoprubart beats tacrolimus on kidney function and quality of life in BESTOW trial
Phase 2 BESTOW trial results show tegoprubart preserved kidney function better than tacrolimus and improved patient-reported quality of life in ...
Tag: anti-CD40L antibody
POPULAR NEWS
-
Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant
-
Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast
-
ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth
-
Systematic review maps sustainability tensions in offshore wind development